These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
866 related items for PubMed ID: 25300967
21. Structural origin of polymorphism of Alzheimer's amyloid β-fibrils. Agopian A, Guo Z. Biochem J; 2012 Oct 01; 447(1):43-50. PubMed ID: 22823461 [Abstract] [Full Text] [Related]
22. A synchrotron-based hydroxyl radical footprinting analysis of amyloid fibrils and prefibrillar intermediates with residue-specific resolution. Klinger AL, Kiselar J, Ilchenko S, Komatsu H, Chance MR, Axelsen PH. Biochemistry; 2014 Dec 16; 53(49):7724-34. PubMed ID: 25382225 [Abstract] [Full Text] [Related]
23. Substituted tryptophans at amyloid-β(1-40) residues 19 and 20 experience different environments after fibril formation. McDonough RT, Paranjape G, Gallazzi F, Nichols MR. Arch Biochem Biophys; 2011 Oct 16; 514(1-2):27-32. PubMed ID: 21843498 [Abstract] [Full Text] [Related]
24. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ1-42 fibrils in Alzheimer's disease: insight from in-vitro and in-silico studies. Hojati S, Ghahghaei A, Lagzian M. J Biomol Struct Dyn; 2018 Jun 16; 36(8):2118-2130. PubMed ID: 28633568 [Abstract] [Full Text] [Related]
25. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation. Takahashi T, Mihara H. Acc Chem Res; 2008 Oct 16; 41(10):1309-18. PubMed ID: 18937396 [Abstract] [Full Text] [Related]
30. Site-specific glycation of Aβ1-42 affects fibril formation and is neurotoxic. Ng J, Kaur H, Collier T, Chang K, Brooks AES, Allison JR, Brimble MA, Hickey A, Birch NP. J Biol Chem; 2019 May 31; 294(22):8806-8818. PubMed ID: 30996005 [Abstract] [Full Text] [Related]
31. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42. Finder VH, Vodopivec I, Nitsch RM, Glockshuber R. J Mol Biol; 2010 Feb 12; 396(1):9-18. PubMed ID: 20026079 [Abstract] [Full Text] [Related]
32. N-terminal domain of myelin basic protein inhibits amyloid beta-protein fibril assembly. Liao MC, Hoos MD, Aucoin D, Ahmed M, Davis J, Smith SO, Van Nostrand WE. J Biol Chem; 2010 Nov 12; 285(46):35590-8. PubMed ID: 20807757 [Abstract] [Full Text] [Related]
33. Studies of Polymorphism of Amyloid-β42 Peptide from Different Suppliers. Suvorina MY, Selivanova OM, Grigorashvili EI, Nikulin AD, Marchenkov VV, Surin AK, Galzitskaya OV. J Alzheimers Dis; 2015 Nov 12; 47(3):583-93. PubMed ID: 26401694 [Abstract] [Full Text] [Related]
36. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. Tõugu V, Karafin A, Zovo K, Chung RS, Howells C, West AK, Palumaa P. J Neurochem; 2009 Sep 12; 110(6):1784-95. PubMed ID: 19619132 [Abstract] [Full Text] [Related]
38. Preparation and characterization of a highly soluble Aβ1-42 peptide variant. LeVatte MA, Lipfert M, Ladner-Keay C, Wishart DS. Protein Expr Purif; 2019 Dec 12; 164():105480. PubMed ID: 31425755 [Abstract] [Full Text] [Related]
39. Understanding Osaka mutation polymorphic Aβ fibril response to static and oscillating electric fields: insights from computational modeling. Makhkamov M, Baev A, Kurganov E, Razzokov J. Sci Rep; 2024 Sep 27; 14(1):22246. PubMed ID: 39333193 [Abstract] [Full Text] [Related]